Tissuemed Seals Exit, with 41% IRR over 14 years
We are delighted to announce today the sale of Tissuemed to Becton Dickinson (NYSE: BDX). Tissuemed, the Leeds-based medtech specialist, develops and manufactures self-adhesive films that help surgeons to close and seal sutured and stapled internal tissues. Tissuemed is the last of Shackleton's 2007 vintage investments to be sold. It has achieved strong growth and profitability in recent years and has been paying dividends. This [...]
